FDA Inspection 1308838 — Cerovene Inc.

Cerovene Inc. — FEI 3005890568

The FDA completed an inspection of Cerovene Inc. on March 23, 2026 in Valley Cottage, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 23, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Valley Cottage, NY (United States)